Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Edner

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 21, 2015
Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure RegistryJenny Berg, Peter Lindgren, Märit Mejhert, et al.
Heart (British Cardiac Society)|June 3, 2015
Risk factors, treatment and prognosis in men and women with heart failure with and without diabetesIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Circulation. Heart Failure|February 7, 2013
Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort studyLars H Lund, Bodil Svennblad, Håkan Melhus, et al.
Upsala Journal of Medical Sciences|August 11, 2018
The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failureGianluigi Savarese, Peter Vasko, Åsa Jonsson, et al.
International Journal of Cardiology|May 14, 2014
Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in SwedenTonje Thorvaldsen, Lina Benson, Inger Hagerman, et al.
International Journal of Cardiology|July 19, 2012
Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure RegistryAlexandra Holmström, Runa Sigurjonsdottir, Magnus Edner, et al.
Scandinavian Journal of Primary Health Care|November 15, 2019
Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure registerBjörn Eriksson, Per Wändell, Ulf Dahlström, et al.
Journal of the American College of Cardiology|October 29, 2013
Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?Tonje Thorvaldsen, Lina Benson, Marcus Ståhlberg, et al.
International Journal of Cardiology|January 25, 2020
Erratum to "Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum" [Int. J. Cardiol. 298 (2019) 59-68]Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
JAMA|January 13, 2011
Association of candesartan vs losartan with all-cause mortality in patients with heart failureMaria Eklind-Cervenka, Lina Benson, Ulf Dahlström, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 21, 2015
Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure RegistryJenny Berg, Peter Lindgren, Märit Mejhert, et al.
Heart (British Cardiac Society)|June 3, 2015
Risk factors, treatment and prognosis in men and women with heart failure with and without diabetesIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.
Circulation. Heart Failure|February 7, 2013
Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort studyLars H Lund, Bodil Svennblad, Håkan Melhus, et al.
Upsala Journal of Medical Sciences|August 11, 2018
The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failureGianluigi Savarese, Peter Vasko, Åsa Jonsson, et al.
International Journal of Cardiology|May 14, 2014
Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in SwedenTonje Thorvaldsen, Lina Benson, Inger Hagerman, et al.
International Journal of Cardiology|July 19, 2012
Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure RegistryAlexandra Holmström, Runa Sigurjonsdottir, Magnus Edner, et al.
Scandinavian Journal of Primary Health Care|November 15, 2019
Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure registerBjörn Eriksson, Per Wändell, Ulf Dahlström, et al.
Journal of the American College of Cardiology|October 29, 2013
Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?Tonje Thorvaldsen, Lina Benson, Marcus Ståhlberg, et al.
International Journal of Cardiology|January 25, 2020
Erratum to "Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum" [Int. J. Cardiol. 298 (2019) 59-68]Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
JAMA|January 13, 2011
Association of candesartan vs losartan with all-cause mortality in patients with heart failureMaria Eklind-Cervenka, Lina Benson, Ulf Dahlström, et al.
Pageof 6